Laura Miró, Júlia López, Pedro E Guerrero, Neus Martínez-Bosch, Noemí Manero-Rupérez, Mireia Moreno, M Rosa Ortiz, Esther Llop, Pilar Navarro, Rosa Peracaula. "Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice." Cancers 14 (2022): 6133-. Adrià Duran; Pedro Enrique Guerrero; Maria Rosa Ortiz; Dúnia Pérez del Campo; Ernesto Castro; Adelaida Garcia-Velasco; Esther Fort; Rafael de Llorens; Radka Saldova; Esther Llop; Rosa Peracaula "Characterization of mesothelin glycosylation in pancreatic cancer: decreased core fucosylated glycoforms in pancreatic cancer patients' sera." Biomedicines 10 (2022): 1942-. Benito Mundet, Helena; Llop Escorihuela, Esther; Verdaguer Planas, Marta; Comas Matas, Joaquim; Lleonart Sitjar, Ariadna; Orts Alis, Marta; Amadó Codony, Anna; Rostan Sánchez, Carles "Multidimensional research on university engagement using a mixed method approach." XXI : revista de educación 24 (2021): 65-96. Greville G; Llop E; Howard J; Madden SF; Perry AS; Peracaula R; Rudd PM; McCann A; Saldova R. "5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells." Clinical Epigenetics 13 (2021): -. Pedro Enrique Guerrero; Adrià Duran; Maria Rosa Ortiz; Ernesto Castro; Adelaida Garcia-Velasco; Esther Llop; Rosa Peracaula "Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl-Lewis x (sLex) in pancreatic adenocarcinoma." Journal of Proteomics 231 (2021): 104004-. Anna Gratacós-Mulleras, Adrià Duran, Akram Asadi Shehni, Montserrat Ferrer-Batallé, Manel Ramírez, Josep Comet, Rafael de Llorens, Radka Saldova, Esther Llop, Rosa Peracaula "Characterisation of the main PSA glycoforms in aggressive prostate cancer." Scientific Reports 10 (2020): -. Pedro Enrique Guerrero , Laura Miró, Bin S Wong,, Anna Massaguer, Neus Martínez-Bosch, Rafael de Llorens, Pilar Navarro, Konstantinos Konstantopoulos, Esther Llop, Rosa Peracaula "Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion." International Journal of Molecular Sciences (2020): -. Greville G, Llop E, Huang C, Creagh-Flynn J, Pfister S, O'Flaherty R, Madden SF, Peracaula R, Rudd PM, McCann A, Saldova R "Hypoxia Alters Epigenetic and N-Glycosylation Profiles of Ovarian and Breast Cancer Cell Lines in-vitro." Frontiers in Oncology (2020): -. Llop E, E Guerrero P, Duran A, Barrabés S, Massaguer A, José Ferri M, Albiol-Quer M, de Llorens R, Peracaula R. "Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma." World Journal of Gastroenterology 24 (2018): 2537-2554. Meritxell Balmaña; Adrià Duran; Catarina Gomes; Esther Llop; Raquel López-Martos; M.Rosa Ortiz; Sílvia Barrabés; Celso A. Reis; Rosa Peracaula "Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues." International Journal of Biological Macromolecules 112 (2018): 33-45. Barrabés, S.; Llop, E.; Ferrer-Batallé, M.; Ramírez, M.; Aleixandre, R.N.; Perry, A.S.; de Llorens, R.; Peracaula, R. "Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer." Clinica Chimica Acta 470 (2017): 97-102. Ferrer-Batallé M; Llop E; Ramírez M; Aleixandre RN; Saez M; Comet J; De Llorens R; Peracaula R "Comparative study of blood-based biomarkers, α2,3-sialic acid PSA and PHI, for high risk prostate cancer detection." International Journal of Molecular Sciences 18 (2017): 845-. Barrabés, S.; Farina-Gomez, N.; Llop, E.; Puerta, A.; Diez-Masa, J.C.; Perry, A.; de Llorens, R.; de Frutos, M.; Peracaula, R. "Comparative analysis of prostate-specific antigen by two-dimensional gel electrophoresis and capillary electrophoresis." Electrophoresis 38 (2017): 408-416. Llop, E.; Ferrer-Batallé, M.; Barrabés, S.; Guerrero, P.E.; Ramírez, M.; Saldova, R.; Rudd, P.M.; Aleixandre, R.N.; Comet, J.; de Llorens, R.; Peracaula, R. "Improvement of Prostate Cancer diagnosis by detecting PSA glycosylation-specific changes." Theranostics 6 (2016): 1190-1204. Balmaña, Meritxell; Giménez, Estela; Puerta, Ángel; Llop, Esther; Figueras, Joan; Fort, Esther; Sanz-Nebot, Victòria; Bolós, Carme de; Rizzi, Andreas; Barrabés, Sílvia; Frutos, Mercedes de; Peracaula, Rosa "Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer." Journal of Proteomics 132 (2016): 144-154. Bassagañas, S; Allende, H; Cobler, L; Ortiz, M.R; Llop, E; de Bolós, C; Peracaula, R. "Inflammatory citokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines." Cytokine 75 (2015): 197-206. Meritxell Balmaña; Ariadna Sarrats; Esther Llop; Sílvia Barrabés; Radka Saldova; Maria-José Ferri; Joan Figueras; Esther Fort; Rafael de Llorens; Pauline M Rudd; Rosa Peracaula "Identification of potential pancreatic cancer serum markers: increased sialyl-Lewis X on ceruloplasmin." Clinica Chimica Acta 442 (2015): 56-62. Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R. "α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues." The International Journal of Biochemistry and Cell Biology 45 (2013): 1748-1757. Martínez-Martínez I, Ordóñez A, Navarro-Fernández J, Pérez-Lara A, Gutiérrez-Gallego R, Giraldo R, Martínez C, Llop E, Vicente V, Corral J. "Antithrombin Murcia (K241E) causing antithrombin deficiency: a role for altered glycosylation.." Haematologica : the Hematology Journal 95 (2010): 1358-1365. Mallorquí J; Llop E; de Bolós C; Gutiérrez-Gallego R; Segura J; Pascual JA. "Purification of erythropoietin from human plasma samples using an immunoaffinity well plate." Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 878 (2010): 2117-2122. Izquierdo-Rico MJ, Jiménez-Movilla M, Llop E, Pérez-Oliva AB, Ballesta J, Gutiérrez-Gallego R, Jiménez-Cervantes C, Avilés M. "Hamster Zona Pellucida is formed by four glycoproteins: ZP1, ZP2, ZP3, and ZP4.." Journal of Proteome Research 8 (2009): 926-941. Llop E, Gutiérrez-Gallego R, Segura J, Mallorquí J, Pascual JA. "Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, DynepoTM). ." Analytical Biochemistry 383 (2008): 243-254. Ramírez-Llanelis R, Llop E, Ventura R, Segura J, Gutiérrez-Gallego R. "Can glycans unveil the origin of glycoprotein hormones? – human chorionic gonadotrophin as an example.." Journal of Mass Spectrometry 43 (2008): 936-948. Llop E, Gutiérrez-Gallego R, Belalcazar V, Gerwig GJ, Kamerling JP, Segura J, Pascual JA. "Evaluation of protein N-glycosylation in 2-DE: Erythropoietin as a study case.." Proteomics 7 (2007): 4278-4291. Belalcazar V, Gutiérrez-Gallego R, Llop E, Segura J, Pascual JA. "Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine.." Electrophoresis 27 (2006): 4387-4395.
Peracaula R; Sarrats A; Balmaña M, Llop E; Barrabés S; Saldova R; Comet J, Figueras J, Rudd PM, Llorens R "Altered Glycosylation of Serum Glycoproteins as Tumour Biomarkers - the Case of Prostate-specific Antigen in Prostate Cancer and the Case of Acute-phase Proteins in Pancreatic Adenocarcinoma." European Journal of Cancer 48, suppl. 5 (2012): S25-S288.
Esther Llop, Ana Ardá, Elsa Zacco, Roisin O'Flaherty, María-Salud García-Ayllón, Massimo Aureli, Moran Frenkel-Pinter, Celso A Reis, Ole K Greiner-Tollersrud, Inmaculada Cuchillo-Ibáñez "Proceedings of workshop: 'Neuroglycoproteins in health and disease', INNOGLY cost action.." Glycoconjugate Journal 39 (2022): 579-586.
Gutiérrez-Gallego R; Llop E; Bosch J; Segura J. "Surface Plasmon Resonance in doping analysis.." Analytical and Bioanalytical Chemistry 401 (2011): 389-403. Pascual JA, Belalcazar V, de Bolós C, Gutiérrez-Gallego R, Llop E, Segura J. "Recombinant erythropoietin and analogues: a challenge for doping control.." Therapeutic Drug Monitoring 26 (2004): 175-179.